Brown, L. C., Halabi, S., Schonhoft, J., Luo, J., Nanus, D. M., Giannakakou, P., … Armstrong, A. J. (2020). Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38). San Francisco, CA: AMER SOC CLINICAL ONCOLOGY.

Brown, Landon Carter, Susan Halabi, Joseph Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou, Russell Zelig Szmulewitz, et al. “Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38. AMER SOC CLINICAL ONCOLOGY, 2020.

Brown LC, Halabi S, Schonhoft J, Luo J, Nanus DM, Giannakakou P, et al. Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.

Brown, Landon Carter, et al. “Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 6, AMER SOC CLINICAL ONCOLOGY, 2020.

Brown LC, Halabi S, Schonhoft J, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Somarelli J, Scher HI, Wenstrup R, Berry WR, Tagawa ST, Antonarakis ES, George DJ, Armstrong AJ. Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2020.